The World Anti-Doping Agency (WADA) prohibits AOD-9604 as a non-approved substance and potential performance-enhancing agent
[3] It is examined for its role in peptide-metal interactions, redox signaling, and metalloproteinase regulation
This peptide formulation combines GLP3, a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, with cagrilintide, a long-acting amylin analog, creating a dual-mechanism research tool that addresses metabolic dysfunction through complementary pathways
Behind the possible downsides There are potential safety concerns, but given the lack of human data, they are not truly known, Muller said
If the reconstituted solution shows any discoloration, particles or if anything similar is observed, discard it immediately